Paige Meizlik
Indianapolis Zoo(US)Triangle(US)National Center on Birth Defects and Developmental Disabilities(US)GlaxoSmithKline (United States)(US)Committee on Publication Ethics(GB)Gainesville Obstetrics & Gynecology(US)
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, Reproductive System and Pregnancy, Pregnancy and Medication Impact
Most-Cited Works
- → Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports(2022)36 cited
- → Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry(2022)29 cited
- → Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea(2021)21 cited
- → Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years(2022)17 cited
- → Safety of belimumab in adult patients with systemic lupus erythematosus: Results of a large integrated analysis of controlled clinical trial data(2022)15 cited
- → Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data